Stage IVB Gallbladder Cancer
5 clinical trials · Condition
◉ Watch Stage IVB Gallbladder Cancer
| Record | Firm | Date |
|---|---|---|
| Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery (NCT02042443) | National Cancer Institute (NCI) | 2014-02-01 |
| ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer (NCT01825603) | University of Nebraska | 2013-04-09 |
| Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery (NCT01859182) | National Cancer Institute (NCI) | 2013-01-01 |
| Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies (NCT01643499) | University of Chicago | 2012-03-26 |
| Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer (NCT00075504) | National Cancer Institute (NCI) | 2003-11-01 |
Track Stage IVB Gallbladder Cancer automatically
Every clearance here is in the API, with alerts when new ones post.